Biotech Stocks: Mannkind, Nektar battered by Pfizer warning

Drug stocks were mixed in early trading Wednesday, as shares of inhaled insulin developer Mannkind Corp. were battered by news that a rival product marketed by Pfizer Inc. and Nektar Therapeutics may have triggered lung cancer in a small number of... 7 months ago